News
Letter of intent between Medical University of Warsaw (WUM) and FamiCordTx signed
There is no translation available.Rector of the Medical University of Warsaw prof. Mirosław Wielgoś and representatives of the FamiCordTx company: Dr Tomasz Baran - President of the Management Board and Dr Tomasz Ołdak - Member of the Management Board - signed aletter of intent regarding cooperation...
MoreInnovative therapy for FamiCord Group Clients
There is no translation available.FamiCord Group Expanded AccessProtocol Cord Blood for Cerebral Palsy Information for the Parent FamiCord Group’s Treatment Program is aBreakthrough in the Use of the Patients’ Own Stem Cells FamiCord Group launches atreatment program of using autologous cord...
MorePBKM started cooperation with Dystrogen Therapeutics
There is no translation available.The Polish Stem Cell Bankestablished cooperation with the biotechnology company Dystrogen Therapeutics. The agreement will enable joint research on chimeric cells and PBKM's production of ATMP stem cells based medicinal products - PBKM informed in apress release. Dy...
MoreAcquisition of BioCell Lugano, Switzerland
There is no translation available. FamiCord Group acquired BioCell Lugano with amodern laboratory in Switzerland. This is another important step towards expanding the scope of activities in Europe.
More